Exhibit II
to
Schedule 13G
Joint Filing Agreement
The undersigned persons agree and consent to the joint filing on their behalf of this Schedule 13G dated January 10,2023 in connection with their beneficial ownership of Eiger BioPharmaceuticals, Inc.. Each of Columbia Seligman Technology and Information Fund and Columbia Management Investment Advisers, LLC authorizes Ameriprise Financial, Inc. to execute the Schedule 13G to which this Exhibit is attached and make any necessary amendments thereto.
Ameriprise Financial, Inc. | ||
| By: | /s/ Michael G. Clarke | |
| Name: | Michael G. Clarke | |
| Title: | Senior Vice President, Head of Global Operations | |
Columbia Management Investment Advisers, LLC | ||
| By: | /s/ Michael G. Clarke | |
| Name: | Michael G. Clarke | |
| Title: Senior Vice President, Head of Global Operations | ||
Columbia Seligman Technology and Information Fund | ||
| By: | /s/ Michael G. Clarke | |
| Name: | Michael G. Clarke | |
| Title: | Senior Vice President & Chief Financial Officer | |